Genomics Market worth $19.0 Billion by 2018

1
MarketsandMarkets Presents
Genomics Market worth 19.0 Billion by 2018

2

• New analysis from Markets and Markets "Genomics
  Market by Products - Instruments (NGS platform,
  Microarray, RT-PCR), Consumables (Gene chips,
  Reagents for DNA Extraction Purification,
  Sequencing), Services (Sequencing Microarray
  Services, and Software) - Global Forecast to
  2018" finds that the Global Genomics Market
  earned revenues of 11.11 billion in 2013 and
  estimates this market to reach over 19.0 billion
  by 2018.
• Browse 49 market data tables and 52 figures
  spread through 248 pages and in-depth TOC on
  Genomics Market by Products- Instruments (NGS
  platform, Microarray, RT-PCR), Consumables (Gene
  chips, Reagents for DNA Extraction
  Purification, Sequencing), Services (Sequencing
  Microarray Services, and Software) - Global
  Forecast to 2018"
• http//www.marketsandmarkets.com/Market-Reports/g
  enomics-market-613.html

3

4

• The report segments the Global Genomics market by
  products (instrument, consumables, and services),
  by technology (Nucleic acid extraction
  purification, PCR, DNA sequencing, and DNA
  microarray), by application (diagnostics,
  personalized medicine, academic research,
  agriculture animal health, and academic
  research), and by geography (North America,
  Europe, APAC, and RoW). Technological
  advancements (Nanopore sequencing, customized
  microarray, and d-PCR), increasing capital
  investment by public and private capitalists in
  genetic researches, as well as innovations in
  bioinformatics tools for advanced application in
  drug discovery and academic research are
  considered the key drivers for the global
  genomics market.
• The future of genomics lies in the personalized
  medicine industry. Government initiatives and
  considerable investments are expected to drive
  genetic research on personalized medicines that
  utilize base pairs of the human genome sequence.

5

• As of now, the application of personalized
  medicine is primarily focused on drug discovery
  for oncology, vaccine production, as well as
  infectious disease-therapeutic areas. The usage
  and application areas for genomic research in
  personalized medicine are expected to increase
  significantly in coming years.
• Over the last decade, Tier I and Tier II
  companies were found to be dominant in the
  instruments and consumables product segments of
  the genomics market. Moreover, increasing market
  consolidation through consecutive restructuring
  activities by leading players has proved to be a
  challenge for new entrants. Market penetration
  in the genomics services sub-segment would be a
  suitable strategy for start-ups. Increasing
  dependency of small and medium scale research
  institutes on outsourced services is expected to
  drive the market significantly, concludes Antan.
  Partnering with Tier I and Tier II manufacturers
  reduces the initial capital investment, and
  allows small scale service providers to leverage
  established brand names for market penetration.
  Leading market players in this market include
  Roche Diagnostic (Switzerland), Life
  Technologies, Corp. (U.S.), QIAGEN (Netherlands),
  Illumina, Inc. (U.S.), and Bio-Rad Laboratories,
  Inc. (U.S.).

6

• The Global Genomics Market study is part of the
  Biotechnology subscription title, which also
  includes research in the following markets Next
  Generation Sequencing (NGS) Market Platforms
  (Illumina HiSeq, MiSeq, Life Technologies Ion
  Proton/PGM, 454 Roche), Bioinformatics (RNA-Seq,
  ChIP-Seq), (Pyrosequencing, SBS, SMRT),
  (Diagnostics, Personalized Medicine) Global
  Forecast to 2017, and Proteomics Market (Protein
  Microarray, Mass Spectrometry, NMR Spectroscopy,
  Chromatography, Electrophoresis, Surface Plasmon
  Resonance, X-ray Crystallography) - Instruments,
  Reagents Services - Trends Global Forecasts
  to 2017.All research reports from Markets and
  Markets provide detailed tables and forecasts
  following extensive interviews with market
  participants.

7
About MarketsandMarkets
Markets and Markets is a global market research
and consulting company based in the U.S. We
publish strategically analyzed market research
reports and serve as a business intelligence
partner to Fortune 500 companies across the
world. Markets and Markets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotive and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at Markets and
Markets are inspired to help our clients grow by
providing apt business insight with our huge
market intelligence repository.
8
Contact Us
Mr. RohanMarkets and Markets UNIT no 802, Tower
no. 7, SEZ Magarpatta city, Hadapsar Pune,
Maharashtra 411013, India 1-888-600-6441 Email
sales_at_marketsandmarkets.com Visit
MarketsandMarkets Blog _at_ http//mnmblog.org/market
-research/healthcare/medical-devices Connect
with us on LinkedIn _at_ http//www.linkedin.com/comp
any/marketsandmarkets